美国资助的在几内亚比绍进行的乙型肝炎疫苗试验因对不向新生儿提供经证实的疫苗的道德关切而停止。 A U.S.-funded hepatitis B vaccine trial in Guinea-Bissau was halted over ethics concerns for withholding a proven vaccine from newborns.

据非洲疾控中心称,美国资助的几内亚比绍乙型肝炎疫苗研究在道德关切下被取消。 非洲疾控中心称,该试验的设计令人无法接受,因为它扣留了高流行率地区新生儿的经证实的疫苗。 A U.S.-funded hepatitis B vaccine study in Guinea-Bissau has been canceled amid ethical concerns, according to Africa CDC, which cited the trial’s design as unacceptable for withholding a proven vaccine from newborns in a high-prevalence region. 由美国卫生与公众服务秘书罗伯特·肯尼迪监督的160万美元研究因有可能使婴儿感染可预防的疾病而面临批评。 The $1.6 million study, overseen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., faced criticism for potentially exposing infants to preventable disease. 非洲疾控中心确认这一停止,并强调今后的任何研究都必须符合严格的道德标准,支持重新设计工作。 Africa CDC confirmed the halt and emphasized that any future research must meet strict ethical standards, supporting redesign efforts. 虽然一些几内亚比绍官员表示有兴趣继续研究,但如果不进行重大修改,研究报告将无法向前推进。 While some Guinea-Bissau officials expressed interest in proceeding, the study will not move forward without significant changes. 这项决定反映了对国际研究做法的日益严格审查,以及推动在全球卫生研究中加强道德监督。 The decision reflects growing scrutiny of international research practices and a push for stronger ethical oversight in global health studies.